Home › Funds › Jones Hill Capital LP › SNDX
Jones Hill Capital LP position in SNDX
SYNDAX PHARMACEUTICALS INC · Health Care
Jones Hill Capital LP reported holding 340,000 shares of SNDX (SYNDAX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$7.4M, representing 1.58% of its reported portfolio and ranking #20 among its reported holdings. Jones Hill Capital LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Jones Hill Capital LP's SNDX position evolved
Jones Hill Capital LP first disclosed a stake in SNDX in Q2 2026 at 340,000 shares (US$7.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 340.00K | $7.43M | New |
About SNDX and 13F data
SNDX (SYNDAX PHARMACEUTICALS INC) is a Health Care company. 43 other funds we track also report a position in SNDX — the largest reported positions include Kynam Capital Management, LP (US$176.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$82.6M), Eversept Partners, LP (US$61.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SNDX
- Kynam Capital Management, LP 8.05M sh · $175.99M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 3.78M sh · $82.63M · Q2 2026
- Eversept Partners, LP 2.80M sh · $61.17M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 2.50M sh · $54.65M · Q2 2026
- Elmind Capital, LP 1.85M sh · $40.55M · Q2 2026
- Soleus Capital Management, L.P. 1.63M sh · $35.59M · Q2 2026
- ORBIMED ADVISORS LLC 1.54M sh · $33.71M · Q2 2026
- MPM BioImpact LLC 1.33M sh · $29.15M · Q2 2026
- Aisling Capital Management LP 1.32M sh · $28.79M · Q2 2026
- Catalio Capital Management, LP 1.22M sh · $26.58M · Q2 2026
- Prosight Management, LP 1.20M sh · $26.23M · Q2 2026
- Trails Edge Capital Partners, LP 1.11M sh · $24.26M · Q2 2026
More on Jones Hill Capital LP
FAQ
How long has Jones Hill Capital LP held SNDX?
Jones Hill Capital LP has disclosed SNDX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Jones Hill Capital LP's current position in SNDX?
As of Q2 2026, Jones Hill Capital LP holds 340.00K shares of SNDX (SYNDAX PHARMACEUTICALS INC), valued at $7.43M, representing 1.58% of its reported portfolio and ranking #20.
Has Jones Hill Capital LP been buying or selling SNDX?
In the latest 13F filing (Q2 2026), Jones Hill Capital LP newly opened its position in SNDX.
Which other funds hold SNDX?
Other major institutional holders of SNDX include Kynam Capital Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P., Eversept Partners, LP, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.